Several lines of evidence identify aberrant excitatory-inhibitory neural processes across 24 autism and schizophrenia spectrum disorders, particularly within the psychosocial domain. 25 Such neural processes include increased excitatory glutamate and reduced inhibitory GABA 26 concentrations, which may affect auditory pre-attentive processing as indexed by the 27 mismatch negativity (MMN); thus, an excitation-inhibition imbalance might lead to aberrant 28 MMN, which might in turn drive the relationship between the MMN and psychosocial 29 difficulties. This research has the potential to enhance the neurochemical understanding of 30 the relationship between electrophysiology (MMN) and behavioural/clinical measures 31 (psychosocial difficulties). 32 Thirty-eight adults (18 male, 18-40 years) completed the Schizotypal 33 Personality Questionnaire (SPQ) and Autism-Spectrum Quotient (AQ). Glutamate 34 and GABA concentrations in bilateral superior temporal cortex (STC) were quantified 35 using proton magnetic resonance spectroscopy (1H-MRS) while auditory MMN to a 36 duration deviant was measured with magnetoencephalography. Spearman 37 correlations probed the relationships between STC glutamate/GABA ratios, MMN 38 amplitude and latency, and AQ and SPQ dimensions. Mediation effects of 39 glutamate/GABA ratios on the relationship between MMN and AQ-SPQ dimensions 40 were probed using causal mediation analysis. 41 Only SPQ-interpersonal and AQ-communication were significantly correlated 42 with right hemisphere glutamate/GABA ratios and MMN latency (ps<.05), which 43 were themselves correlated (p=.038). Two mediation models were investigated, with 44 right MMN latency as predictor and SPQ-interpersonal and AQ-communication as 45 outcome variables. Right STC glutamate/GABA ratios significantly mediated the 46 relationship between MMN latency and SPQ-interpersonal scores (ß=86.6, p=.033), 47 but only partially mediated the relationship between MMN latency and AQ-48 communication scores (ß=21.0, p=.093). 49 These findings support the growing body of literature pointing toward an 50 excitation-inhibition imbalance that is central to psychosocial functioning across 51 multi-dimensional spectrum disorders, such as autism and schizophrenia, and 52 provides neurochemical indicators of the processes that underlie psychosocial 53 dysfunction. 54 3 55
Ketamine, an NMDA antagonist, has also been shown to increase glutamate and 88 glutamine (a putative marker of glutamate transmitter release) concentrations in the 89 anterior cingulate cortex (Rowland et al., 2016; Stone et al., 2012) , and a recent meta-90 analysis demonstrated increased glutamate and glutamate+glutamine (Glx) concentrations 91 for schizophrenia patients across the basal ganglia, and temporal and frontal regions 92 (Merritt et al., 2016) . al., 2011). However, the extent to which the relationship between the MMN and 101 psychosocial deficits is modulated by excitatory-inhibitory processes is not yet known. 102
In healthy populations, higher Glx concentrations in the superior temporal cortex 103 have been associated with shorter MMN latency and slightly increased MMN amplitude 104 (Kompus et al., 2015) , while hippocampal glutamate/creatine ratios were associated with 105 MMN amplitudes measured from temporal (not frontal or central) electrode sites (Chitty et 106 al., 2015) , and frontally recorded MMN amplitude was not associated with anterior 107 cingulate glutamate or GABA concentrations (Rowland et al., 2016) . These relationships 108
were more specific to deviations in stimulus duration, not frequency, which is thought to 109 reflect the complexity of duration tone changes, compared to frequency (Todd et al., 2008 (Todd et al., , 110 2003 ). Furthermore, deviations in the duration of tones might rely on multiple system 111 integration, or a specific neural system, that is governed by glutamatergic 112 neurotransmission (Kompus et al., 2015) . Duration tone deviants may, therefore, rely more 113 heavily on multisystem integration, and be more sensitive in detecting differences in 114 psychiatric disorders (Kompus et al., 2015; Todd et al., 2003) . 115
In psychiatric populations, reduced glutamate and GABA concentrations in the 116 anterior cingulate have been associated with reduced frontally recorded duration deviant 117 MMN for schizophrenia patients (Rowland et al., 2016) , and hippocampal 118 glutamate/creatine ratios were associated with duration MMN amplitudes from temporal 119 (not frontal or central) electrode sites in healthy controls, but not bipolar patients 120 (Chitty et al., 2015) . A more recent combined schizophrenia and bipolar study 121 reported that increased frontal and right temporal duration MMN was associated 122 with higher anterior cingulate glutamate/creatine ratios for schizophrenia patients 123 only, while reduced MMN peak amplitude at frontal and temporal sites was 124 associated with increased hippocampal glutamate/creatine, albeit not significantly 125 (Kaur et al., 2019) . It is important to note that these studies did not report on 126 Participant recruitment and data collection procedures for this study have been described 158 previously (Ford et al., 2017a (Ford et al., , 2017d Ford and Crewther, 2014) . Initially, 1,678 adults aged 159 18 to 40 years (428 male, 1250 female) were recruited to complete an online questionnaire 160 consisting of the autism-spectrum quotient (AQ) and the schizotypal personality 161 questionnaire (SPQ). The AQ and SPQ subscales were entered into an exploratory factor 162 analysis to identify latent factors that exist within the autism-schizotypy spectra; a 163 combined autism-schizotypy factor was revealed and termed Social Disorganisation (Ford 164 and Crewther, 2014). Participants scoring in the top and bottom 20% of Social 165
Disorganisation scores were invited to participate in a follow-up neuroimaging study 166 involving MEG and 1H-MRS. The first 10 male and 10 female responders from each end of 167 the Social Disorganisation distribution were recruited. In total, 38 participants took part in 168 the neuroimaging study (20 female, 18 male). 169
One female participant was excluded due to reporting current psychoactive 170 medications; of the remaining participants, five self-reported a previous psychiatric 171 condition (3 depression, 1 bipolar, 1 anorexia). No participant reported a previous or current 172 autism or schizophrenia spectrum condition, and none were affected by a psychiatric 173 condition at the time of the study. All participants reported being free of illicit drug and 174 cigarette effects at the time of the MEG and MRI scans. 1998) editing sequence was applied to quantify temporal GABA concentrations (TE = 68ms, 216 TR = 1500ms, bandwidth = 1000Hz, edit-on pulse frequency = 1.9ppm, edit-off pulse 217 frequency = 7.5ppm, edit pulse bandwidth = 44Hz, 120 averages, 12 spectral unsuppressed 218 water averages, duration = 6min 6 sec). As an edit-off pulse at 7.5ppm does not suppress 219 macromolecular concentrations at 3.0ppm, the spectra included macromolecules (GABA+). 220
For all scans, chemical shift selective (CHESS; Haas, 1986) water suppression was applied, 221 and automatic and manual shimming was conducted to achieve full-width half maximum 222 Supplementary Table 1) . 244
For quantification of GABA with Gannet, edit-on and edit-off spectra were 245 subtracted to reveal GABA+ concentration at 3.00ppm relative water, resulting in 246 The MEG protocol utilised in this study has been reported in detail previously (Ford et al., 257 2017c ). In brief, continuous MEG data were collected using a whole-head 306 channel 258
Elekta Neuromagâ TRIUX magnetometer system (Helsinki, Finland; Elekta, 2016) within a 259 magnetically shielded room, with external active shielding on, at a rate of 1000Hz with a 260
.1Hz high-pass filter. Five continuous head position 1 indicators tracked head position in 261 relation to magnetometers, and head shape was digitised using a Polhemus FASTRACK 262 system (Polhemus Inc., Colchester, VT, United States of America). Blink artefact and heart 263 rate artefact were detected using electrodes placed above and below the right eye, and on 264 the right wrist, respectively. A reference electrode was positioned on the right elbow. 265
Participants were seated and watched a silent film while passive MMN stimuli were 266 presented binaurally through Etymotic headphones. Stimuli consisted of three blocks of 267 standard tones (50ms, 1000Hz, 85% of stimuli) randomly interrupted by duration deviants 268 (100ms, 1000Hz, 15% of stimuli). The inter-stimulus interval was 500ms (offset to onset) and 269 each block lasted 4-5 min. Stimuli were created using VPixx version 3.0 with DataPixx (VPixx 270 Technologies Inc., 2016) and calibrated with a Jay Cam sound pressure level meter to 85 dB 271
SPL. 272
For all raw MEG data, MaxFilter (version 2.1; Helsinki, Finland: Elekta, 2016) with Data were first screened for outliers, with STG GABA+ data excluded from 302 two participants (left n = 1, right n = 1). The MMF was not detected on four 303 occasions (left n = 2, right n = 2), and was thus removed from further statistical 304 analyses. Statistical analyses were then conducted on the remaining datasets where 305 femtotesla (fT) milliseconds milliseconds 1H-MRS and MEG data were available for each hemisphere (left n = 32, right n = 33). All 306 analyses were conducted using R (R Core Team, 2014), and the code is available at 307 www.doi.org/10.13140/RG.2.2.29277.56800. 308
Spearman's rank order (r) correlation coefficients were calculated to investigate 309 relationships between the AQ and SPQ subscales, left and right MMF amplitude and latency, 310 and left and right glutamate/GABA+ ratio, and to probe potential mediation models. Only 311 correlation coefficients greater than r = .30 were considered (Tabachnick and Fidell, 2013) .
312
Spearman correlation coefficients for the relationships between the left temporal MMF and 313 left glutamate/GABA ratio were below the r = .30 threshold (see Table 2 ), thus no left to test the significance of the mediation effect using Nonparametric Bootstrap Confidence 325
Intervals with the Percentile Method from the mediation package in R (Tingley et al., 2014) . 326
Data were bootstrapped 10,000 times to calculate the average causal mediation effect 327 (ACME); ACME was considered significant when 95% confidence intervals did not include 328 zero. 329 330
Results 331
Descriptive statistics for AQ subscales, SPQ dimensions, MMF amplitude and latency, and 332 glutamate/GABA+ ratio are presented in Table 1 . There were no sex differences in 333 demographic, MMF or 1H-MRS variables (p > .1), except that SPQ Disorganised features 334
were higher for males than females (p = .030). 335
In the right hemisphere, there was a significant moderate correlation 336 between glutamate/GABA+ ratio and MMF latency, but not MMF amplitude. There 337 were also significant correlations between MMF latency and AQ communication, AQ 338 imagination, SPQ interpersonal features and SPQ disorganised features, and 339 between glutamate/GABA+ ratio and AQ social skills, AQ communication and SPQ 340 interpersonal features (see Table 2 ). Correlations between glutamate, Glx and GABA, 341
and MMF amplitude and latency, are presented in Supplementary Table 2 Discussion 397
This study is the first to investigate the effect of glutamate/GABA+ ratios in auditory 398 processing regions on the relationship between MMF and symptom domains of the autism 399 and schizophrenia spectra. Initial correlational analyses provide preliminary evidence to 400 suggest an interrelationship between right STC glutamate/GABA+ ratios, right MMF latency 401 and symptom domains associated with psychosocial function, such that longer MMF latency 402 was associated with more severe psychosocial deficits, and higher glutamate/GABA+ ratios. contribute to the inconsistencies reported in regional glutamate and GABA 463 concentrations (for review see Ajram et al., 2019; Ford and Crewther, 2016) , 464 although, these inconsistencies could be attributed to actual regional differences in Research has also reported various genetic mutations that may affect 467 excitatory-inhibitory processes in schizophrenia, including those seen in autism (e.g., 468 CNTNAP2, SHANK3, neurexin 1), as well as disruption to the glutamate-GABA 469 metabolism enzymes glutaminase and glutamine synthetase (Bruneau et al., 2005) . 1H-MRS 470 studies have relatively consistently shown increased glutamate, glutamine and Glx across 471 brain regions, which have been associated with negative symptoms (for a review, see Foss-472 region were associated with slightly smaller MMN amplitude in healthy populations, 490 however the MMN was recorded fronto-centrally (Kompus et al., 2015) . This study is the 491 first to report the correlation between MEG-measured MMF and glutamate/GABA+ ratios, 492 and thus may identify a more reliable and localised effect. 493
There was also no relationship observed between left or right MMF amplitude and 494 severity of schizophrenia spectrum domains, which is somewhat surprising given EEG 495 consistently demonstrates reduced MMN in schizophrenia samples; however, the exact 496 mechanisms of this reduction remains unknown (Kargel et al., 2014; Michie et al., 2016; 497 Todd et al., 2008 497 Todd et al., , 2003 . The MMN deficit in schizophrenia has been explained in the 498 context of a predictive coding deficiency, whereby the reduced MMN amplitude represents 499 a neurobiological inefficiency in forming prediction about the environment to reduce 500 prediction error (Friston, 2005; Michie et al., 2016) . A more recent meta-analysis has 501 questioned this theory after reporting no relationship between positive and negative 502 symptoms of schizophrenia and MMN amplitude, suggesting that although MMN is 503 consistently reduced in schizophrenia and at-risk groups, this is independent of 504 symptom severity (Erickson et al., 2017) ; MMN latency was not investigated. Post-505 mortem studies have reported reduction NR1 mRNAs and proteins in schizophrenia, 506 which are essential for NMDAr functionality, and may thus explain the reduced 507 MMN in schizophrenia samples, but this might not translate to a relationship 508 between symptom severity and MMN amplitude (Michie et al., 2016) . The findings 509 herein suggest that the MMN elicited from the auditory cortex at the initial 510 processing stage may not be affected by schizotypal or autism trait severity. 511
It should be noted that the sample size of this study was quite small, with a 512 number of participants' data rejected due to poor quality; thus, the effects observed 513 should be interpreted as a preliminary finding that requires further exploration. In 514 addition, self-report measures, such as the AQ and SPQ, require a degree of 515 introspection that is often missing for those with poor psychosocial functioning. The 516 AQ and SPQ tend to ask participants to report on their personal preferences, 517 however, rather than to rate their own abilities (Baron-Cohen et al., 2001). For this 518 study, we recorded SPQ data on a 4-point Likert scale as per AQ, and pseudo-519 randomised items in an attempt to reduce response bias. 520
Clearly, the hypothesis of abnormal excitation-inhibition cycling in autism and 521 schizophrenia is far from straightforward, and further multimodal research is 522 necessary to better understand the complexity of the pathways contributing to the 523 excitation-inhibition in psychopathology (Foss-Feig et al., 2017). This study utilised 524 two neurological models of excitatory-inhibitory processes using two neuroimaging 525 modalities: MMF with MEG, and glutamate and GABA concentrations with 1H-MRS. 526
The combined use of MEG and 1H-MRS has allowed for the relationship between 527 electrophysiological processes and behavioural outcomes to be better understood in 528 relation to the effect of regional glutamate and GABA concentrations -a direct 529 measure of excitatory and inhibitory processes. 
